Published in Virus Weekly, May 23rd, 2006
"Although 48-week therapy with pegylated-interferons has been shown to be effective for the treatment of chronic hepatitis B virus infection, the efficacy of a shorter duration of therapy with pegylated interferons is unknown," wrote C.K. Hui and colleagues, University of Hong Kong.
They explained, "We reviewed 53 hepatitis B e antigen positive Chinese patients treated with 48 weeks of pegylated interferon...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly